Biorex appoints BioFront Technologies as distributor

By Joseph James Whitworth contact

- Last updated on GMT

BioFront Technologies and Biorex partnership
BioFront Technologies and Biorex partnership
Biorex Food Diagnostics has appointed BioFront Technologies as its North America distributor for its food safety platform.

Biorex products include a range of antibiotics, mycotoxins, hormones and beta-agonists.

The antibiotic kit line has tests for chloramphenicol, nitrofuran metabolites, quinolones, streptomycin, sulfonamides, tetracycline and tylosin.

Mycotoxin kits include aflatoxin and ochratoxin, with a hormonal kit portfolio including diethylstilbestrol, zeranol, trenbolone, clenbuterol, ractopamine and a beta-agonist kit capable of detecting 11 compounds.

Biorex kits can be used in sample matrices including honey, seafood (prawns), urine, milk, feed, nuts and dried fruit.

Dr Morteza Afrasiabi, managing director of Biorex Food Diagnostics, said: “These complimentary ELISA based productswill enable testing laboratories and food producers across the globe to assess exceptional analytical performance in food, feed and animal health.”

The firm also has a fipronil immunoassay screening test for liquid egg. The kit allows egg producers to test 42 samples in their facilities with results available within 75 minutes.

Biorex customers will have access to Biofront’s food allergen test kit line including gluten, peanuts, treenuts, egg, lupin, milk, soy, seeds (sesame, mustard and buckwheat) and shellfish.

The enzyme-linked immuno-sorbent assay (ELISA) kits are designed to detect and quantify trace amounts of allergens in complex food matrices and surface rinses.

Jason Robotham, president of BioFront Technologies, said: “Many of our food allergen customers also perform routine tests for analytes that Biorex detect, and for our US customers, this will make it easier for them to access our Fapas reference materials and PT services for these same analytes, thus ensuring the highest quality standards and confidence in analytical performance.”

Related topics: Rapid analysis, Industry news

Related news

Show more

comments

Post your comment

We will not publish your email address on the website

These comments have not been moderated. You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment. Any comment that violates these terms may be removed in its entirety as we do not edit comments. If you wish to complain about a comment please use the "REPORT ABUSE" button or contact the editors.